Bessemer Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.02M | Buy |
59,061
+18,649
| +46% | +$2.86M | 0.01% | 350 |
|
|
2025
Q4 | $5.57M | Buy |
40,412
+24,436
| +153% | +$3.2M | 0.01% | 398 |
|
|
2025
Q3 | $2.05M | Buy |
15,976
+403
| +3% | +$49.2K | ﹤0.01% | 495 |
|
|
2025
Q2 | $1.88M | Buy |
15,573
+4,284
| +38% | +$483K | ﹤0.01% | 483 |
|
|
2025
Q1 | $1.26M | Buy |
11,289
+1,105
| +11% | +$118K | ﹤0.01% | 611 |
|
|
2024
Q4 | $991K | Sell |
10,184
-1,190
| -10% | -$127K | ﹤0.01% | 766 |
|
|
2024
Q3 | $1.31M | Sell |
11,374
-1,040
| -8% | -$118K | ﹤0.01% | 728 |
|
|
2024
Q2 | $1.32M | Sell |
12,414
-159
| -1% | -$16K | ﹤0.01% | 607 |
|
|
2024
Q1 | $1.22M | Sell |
12,573
-2,398
| -16% | -$246K | ﹤0.01% | 642 |
|
|
2023
Q4 | $1.51M | Buy |
14,971
+263
| +2% | +$25.4K | ﹤0.01% | 548 |
|
|
2023
Q3 | $1.5M | Sell |
14,708
-1,675
| -10% | -$170K | ﹤0.01% | 531 |
|
|
2023
Q2 | $1.65M | Buy |
16,383
+808
| +5% | +$80.8K | ﹤0.01% | 521 |
|
|
2023
Q1 | $1.43M | Sell |
15,575
-1,392
| -8% | -$122K | ﹤0.01% | 515 |
|
|
2022
Q4 | $1.54M | Sell |
16,967
-5,029
| -23% | -$424K | ﹤0.01% | 497 |
|
|
2022
Q3 | $1.67M | Buy |
21,996
+4,159
| +23% | +$345K | ﹤0.01% | 484 |
|
|
2022
Q2 | $1.51M | Sell |
17,837
-261
| -1% | -$22.9K | ﹤0.01% | 500 |
|
|
2022
Q1 | $1.59M | Sell |
18,098
-2,153
| -11% | -$186K | ﹤0.01% | 396 |
|
|
2021
Q4 | $1.77M | Sell |
20,251
-1,323
| -6% | -$110K | ﹤0.01% | 361 |
|
|
2021
Q3 | $1.76M | Sell |
21,574
-491
| -2% | -$44.2K | ﹤0.01% | 326 |
|
|
2021
Q2 | $2.01M | Buy |
22,065
+803
| +4% | +$71.5K | ﹤0.01% | 316 |
|
|
2021
Q1 | $1.82M | Buy |
21,262
+6,594
| +45% | +$592K | ﹤0.01% | 325 |
|
|
2020
Q4 | $1.39M | Buy |
14,668
+334
| +2% | +$29.2K | ﹤0.01% | 353 |
|
|
2020
Q3 | $1.25M | Buy |
14,334
+526
| +4% | +$45.6K | ﹤0.01% | 375 |
|
|
2020
Q2 | $1.21M | Sell |
13,808
-873
| -6% | -$75.4K | ﹤0.01% | 680 |
|
|
2020
Q1 | $1.21M | Sell |
14,681
-203
| -1% | -$18.1K | ﹤0.01% | 554 |
|
|
2019
Q4 | $1.41M | Sell |
14,884
-400
| -3% | -$35.9K | ﹤0.01% | 665 |
|
|
2019
Q3 | $1.33M | Buy |
15,284
+3,238
| +27% | +$291K | ﹤0.01% | 629 |
|
|
2019
Q2 | $1.1M | Sell |
12,046
-893
| -7% | -$75.6K | ﹤0.01% | 684 |
|
|
2019
Q1 | $1.11M | Sell |
12,939
-2,197
| -15% | -$176K | ﹤0.01% | 606 |
|
|
2018
Q4 | $1.16M | Buy |
15,136
+2,962
| +24% | +$231K | 0.01% | 536 |
|
|
2018
Q3 | $940K | Sell |
12,174
-326
| -3% | -$24.1K | ﹤0.01% | 593 |
|
|
2018
Q2 | $846K | Sell |
12,500
-780
| -6% | -$53.8K | ﹤0.01% | 616 |
|
|
2018
Q1 | $963K | Sell |
13,280
-1,193
| -8% | -$90.8K | ﹤0.01% | 592 |
|
|
2017
Q4 | $1.09M | Sell |
14,473
-2,454
| -14% | -$185K | ﹤0.01% | 586 |
|
|
2017
Q3 | $1.3M | Buy |
16,927
+2,989
| +21% | +$226K | 0.01% | 577 |
|
|
2017
Q2 | $1.04M | Sell |
13,938
-6,351
| -31% | -$450K | ﹤0.01% | 652 |
|
|
2017
Q1 | $1.35M | Buy |
20,289
+5,945
| +41% | +$396K | 0.01% | 619 |
|
|
2016
Q4 | $936K | Buy |
14,344
+1,398
| +11% | +$90.7K | ﹤0.01% | 723 |
|
|
2016
Q3 | $916K | Sell |
12,946
-263
| -2% | -$19.2K | ﹤0.01% | 633 |
|
|
2016
Q2 | $977K | Sell |
13,209
-1,834
| -12% | -$127K | 0.01% | 468 |
|
|
2016
Q1 | $977K | Sell |
15,043
-11,705
| -44% | -$796K | 0.01% | 470 |
|
|
2015
Q4 | $2.06M | Buy |
26,748
+12,666
| +90% | +$1.01M | 0.01% | 425 |
|
|
2015
Q3 | $1.16M | Sell |
14,082
-2,010
| -12% | -$179K | 0.01% | 556 |
|
|
2015
Q2 | $1.42M | Buy |
16,092
+4,045
| +34% | +$371K | 0.01% | 496 |
|
|
2015
Q1 | $1.06M | Sell |
12,047
-4,043
| -25% | -$359K | 0.01% | 515 |
|
|
2014
Q4 | $1.34M | Buy |
16,090
+3,803
| +31% | +$315K | 0.01% | 436 |
|
|
2014
Q3 | $1.04M | Sell |
12,287
-521
| -4% | -$42.2K | 0.01% | 451 |
|
|
2014
Q2 | $1.04M | Sell |
12,808
-841
| -6% | -$66.1K | 0.01% | 448 |
|
|
2014
Q1 | $1.04M | Buy |
13,649
+1,013
| +8% | +$73.8K | 0.01% | 417 |
|
|
2013
Q4 | $910K | Buy |
12,636
+1,130
| +10% | +$78.5K | 0.01% | 446 |
|
|
2013
Q3 | $791K | Sell |
11,506
-933
| -8% | -$61.7K | 0.01% | 450 |
|
|
2013
Q2 | $788K | Buy |
+12,439
| New | +$809K | 0.01% | 418 |
|
Other funds holding NVS
Bessemer Group's NVS Position: Q1 2026 in Review
Bessemer Group increased its Novartis (NVS) stake by 46% in Q1 2026, buying an estimated $2.86M and bringing the position to 59,061 shares worth $9.02M. The position accounts for 0.01% of the portfolio, ranked #350.
Bessemer Group first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Bessemer Group held 59,061 shares of Novartis worth $9.02M as of Q1 2026.
- Bessemer Group bought 18,649 Novartis shares in Q1 2026, an estimated $2.86M.
- Novartis made up 0.01% of Bessemer Group's portfolio in Q1 2026, its #350 holding.
- Bessemer Group first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.